Facet Life Sciences Quarterly Update Q2 – 2024
From The Corner Office Q2 2024 Ken [...]
Facet By The Numbers – Q2 2024
FACET BY THE NUMBERS Total ESG submissions to FDA [...]
Go Team! – Q2 2024
Team Focus - New Facet Team Members We are [...]
ICYMI – Q2 2024 – SNMMI’s Mars Shot
Facet Donates to SNMMI’s Mars Shot Facet is proud [...]
ICYMI – Q2 2024 – SNMMI
Facet Attends SNMMI In June, Dr. Lisa Jenkins VanLuvanee [...]
ICYMI – Q2 2024 – Psychedelic Therapeutics & Drug Development Conference
Facet Attends Psychedelic Therapeutics & Drug Development Conference In [...]
ICYMI – Q2 2024 – Market Access Society of America Symposium
Facet Attends the Market Access Society of America Symposium [...]
ICYMI – Q2 2024 – FDLI Annual Conference
Facet Attends the Food and Drug Law Institute (FDLI) [...]
ICYMI – Q2 2024 – PET CMC Coalition
Facet Joins PET CMC Coalition In May, Facet joined [...]
Spotlight On Rare Disease Development – Q2 2024 – START Pilot Program Updates
START Pilot Program Updates In our 4Q2023 newsletter, we [...]
gET sOCIAL